Matica Biotechnology, a CDMO specialising in cell and gene therapies (CGT), has announced a strategic partnership with the National Center for Therapeutics Manufacturing (NCTM), part of the Texas A&M Engineering Experiment Station. The alliance is intended to provide an integrated
Matica Biotechnology (Matica Bio), a contract development and manufacturing organisation (CDMO) specialising in viral vector development, has announced a partnership with Treovir to address critical gaps in paediatric cancer care. Matica Bio will provide GMP manufacturing for clinical supplies of
Matica Biotechnology, a contract development and manufacturing organization (CDMO) specialising in viral vectors, has unveiled a new high-resolution ion-exchange chromatography (IEX) method designed to improve the analysis of AAV8 (Adeno-Associated Virus 8) viral vector capsids. This advancement addresses a key
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) focusing on viral vector manufacturing, has entered into a strategic development partnership with CytoImmune, a biotechnology company based in Puerto Rico. This collaboration aims to advance a clinical
Matica Biotechnology Contract Manufacturing & Development (CDMO) Profile Matica Biotechnology, Inc. is a leading contract development and manufacturing organization (CDMO) specializing in cutting-edge cell and gene therapies, vaccines, and precision medicines. With a team of industry veterans boasting over 15
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
